v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Aug. 01, 2026
Aug. 02, 2025
Operating activities    
Net income $ 8,496 $ 7,257
Add (deduct) items not affecting operating cash flows:    
Depreciation and amortization 1,214 1,534
Allowance for doubtful accounts 51 29
Loss on disposal of property and equipment 0 51
Amortization of deferred financing costs 183 183
Share-based compensation expense 140 242
Capitalized PIK Interest due to loan with former related party 538 491
Equity in net income of equity method investment, net of distributions 1,164 1,281
Changes in assets and liabilities:    
Receivables, net 3,179 3,479
Inventories (7,045) (17,521)
Prepaid expenses and other current assets (944) (1,286)
Accounts payable and accrued expenses 2,688 (1,966)
Other assets and liabilities (434) (1,389)
Net cash provided by (used in) operating activities 9,230 (7,615)
Investing activities    
Payments for capital expenditures (963) (3,530)
Net cash used in investing activities (963) (3,530)
Financing activities    
Proceeds from borrowings under the Revolving Credit Facilities 117,800 115,600
Repayment of borrowings under the Revolving Credit Facilities (125,550) (104,150)
Tax withholdings related to restricted stock vesting (1) 0
Proceeds from issuance of common stock, net of certain fees 0 4
Exercise of stock options 2 0
Financing fees 0 (135)
Net cash (used in) provided by financing activities (7,749) 11,319
Increase in cash, cash equivalents, and restricted cash 518 174
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (7) (4)
Cash, cash equivalents, and restricted cash, beginning of period 557 666
Cash, cash equivalents, and restricted cash, end of period 1,068 836
Less: restricted cash at end of period 59 59
Cash and cash equivalents per balance sheet at end of period 1,009 777
Supplemental Disclosures of Cash Flow Information    
Cash payments for interest 676 962
Cash payments for income taxes, net of refunds 1,524 797
Supplemental Disclosures of Non-Cash Investing and Financing Activities    
Capital expenditures in accounts payable and accrued liabilities $ 427 $ 43